Jazz Pharmaceuticals plc

XNAS:JAZZ   4:00:00 PM EDT
236.28
+1.40 (+0.60%)
7:45:32 PM EDT: $237.22 +0.94 (+0.40%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)15.34B
Current PE16.30
Forward PE 9.44
2yr Forward PE 9.17
See more stats
Estimates Current Quarter
Revenue$1.21 Billion
Adjusted EPS$6.47
See more estimates
10-Day MA$240.36
50-Day MA$248.89
200-Day MA$209.86
See more pivots

Jazz Pharmaceuticals plc Stock, XNAS:JAZZ

Waterloo Exchange, Waterloo Road, Dublin, Dublin 4
Ireland
Phone: +353.1.634.7800
Number of Employees: 2800
http://www.jazzpharmaceuticals.com

Description

Jazz Pharmaceuticals Plc operates as a biopharmaceutical company, which focuses on the identification, development, and commercialization of pharmaceutical products in the areas of narcolepsy, oncology, pain, and psychiatry. Its product portfolio includes: Xyrem, Xywav, Epidolex, Zepzelca, Rylaze, Vyxeos, and Defitelio. The company was founded by Bruce C. Cozadd in March 2003 and is headquartered in Dublin, Ireland.